Correlation Between Candel Therapeutics and Kronos Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Kronos Bio, you can compare the effects of market volatilities on Candel Therapeutics and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Kronos Bio.

Diversification Opportunities for Candel Therapeutics and Kronos Bio

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Candel and Kronos is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Kronos Bio go up and down completely randomly.

Pair Corralation between Candel Therapeutics and Kronos Bio

Given the investment horizon of 90 days Candel Therapeutics is expected to generate 5.21 times less return on investment than Kronos Bio. In addition to that, Candel Therapeutics is 1.7 times more volatile than Kronos Bio. It trades about 0.03 of its total potential returns per unit of risk. Kronos Bio is currently generating about 0.23 per unit of volatility. If you would invest  87.00  in Kronos Bio on September 12, 2024 and sell it today you would earn a total of  18.00  from holding Kronos Bio or generate 20.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Candel Therapeutics  vs.  Kronos Bio

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Kronos Bio 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Kronos Bio displayed solid returns over the last few months and may actually be approaching a breakup point.

Candel Therapeutics and Kronos Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and Kronos Bio

The main advantage of trading using opposite Candel Therapeutics and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.
The idea behind Candel Therapeutics and Kronos Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets